Measuring HIV-related mortality in the first decade of anti-retroviral therapy in sub-Saharan Africa

Global Health Action

Volumn 7, Issue 1, 2014, Pages

  Todd, Jim ^a   Slaymaker, Emma ^a   Zaba, Basia ^a   Mahy, Mary ^b,c   Byass, Peter ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNAIDS   (Switzerland)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGE; EPIDEMIOLOGY; FEMALE; HIV INFECTIONS; HUMAN; MALE; MIDDLE AGED; MORTALITY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGE FACTORS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84904396602     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v7.24787     Document Type: Editorial

References (17)

1. Todd J, Glynn JR, Marston M, Lutalo T, Biraro S, Mwita W, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007; 21 (Suppl 6): S55-63.
2. Floyd S, Marston M, Baisley K, Wringe A, Herbst K, Chihana M, et al. The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level-a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health 2012; 17: e84-93.
3. Maher D, Biraro S, Hosegood V, Isingo R, Lutalo T, Mushati P, et al. Translating global health research aims into action: the example of the ALPHA network. Trop Med Int Health. 2010; 15: 321-8.
4. World Health Organization (2012). WHO verbal autopsy standards: ascertaining and attributing causes of death. Geneva: WHO.
5. Byass P, Calvert C, Miiro-nakiyingi J, Lutalo T, Michael D, Crampin A, et al. InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Action 2013; 6: 22448.
6. Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, et al. All-cause mortality in treated HIVinfected adults with CD4]500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012; 41: 433-45.
7. Stover J, Brown T, Marston M. Updates to the spectrum/estimation and projection package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect 2012; 88(Suppl 2): i11-i16.
8. Kanjala C, Michael D, Todd J, Slaymaker E, Calvert C, Isingo R, et al. Using HIV-attributable mortality to assess the impact of antiretroviral therapy on adult mortality in rural Tanzania. Glob Health Action 2014; 7: 21865.
9. Slaymaker E, Todd J, Marston M, Calvert C, Michael D, Nakiyingi-Miiro J, et al. How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa. Glob Health Action 2014; 7: 22789.
10. Glynn J, Calvert C, Price A, Chihana M, Kachiwanda L, Mboma S, et al. Measuring causes of adult mortality in rural northern Malawi over a decade of change. Glob Health Action 2014; 7: 23621.
11. World Health Organization (2011). World Health Organization: international statistical classification of diseases and related health problems. 10th Rev. Volume 2: Instruction Manual. Available from: http://apps.who.int/classifications/icd10/browse/2010/en [cited 20 May 2014].
12. Oti SO, Wamukoya M, Mahy M, Kyobutungi C. InterVA versus Spectrum: how comparable are they in estimating AIDS mortality patterns in Nairobi's informal settlements? Glob Health Action 2013; 6: 21638.
13. Michael D, Kanjala C, Calvert C, Pretorius C, Wringe A, Todd J, et al. Does the Spectrum model accurately predict trends in adult mortality? Evaluation of model estimates using empirical data from a rural HIV community cohort study in north-western Tanzania. Glob Health Action. 2014; 7: 21783. http://dx.doi.org/10.3402/gha.v7.21783.
14. World Health Organization (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Available from: http://www.who.int/mediacentre/news/releases/2013/new_hiv_recommendations_20130630/en/[cited 16 April 2014].
15. Masiira B, Baisley K, Mayanja BN, Kazooba P, Maher D, Kaleebu P. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ]350 cells/mm3 compared to the general population: data from a population-based prospective HIV cohort in Uganda. Glob Health Action 2014; 7: 21843.
16. Levira F, Masanja H. Coming home to die? The association between migration and mortality in rural Tanzania before and after ART scale-up. Glob Health Action 2014; 7: 22956.
17. Welaga P, Hosegood V, Weiner R, Hill C, Herbst K, Newell M-L. Coming home to die? The association between migration and mortality in rural South Africa. BMC Public Health 2009; 9: 193.